Mutational analysis of muscle and brain specific promoter regions of dystrophin gene in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE)
- PMID: 8808315
- DOI: 10.1006/mcpr.1995.0067
Mutational analysis of muscle and brain specific promoter regions of dystrophin gene in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE)
Abstract
In order to characterize the nature of mutations occurring in non-deleted Duchenne (DMD) and Becker muscular dystrophy (BMD) affected males, a total of 40 unrelated Italian patients was studied for the presence of point mutations within the muscle-specific regulatory region of the dystrophin gene. We decided to investigate the dystrophin promoter sequences because nucleotide variations in these regions could impair the expression of the gene and be the underlying molecular defect in some forms of the disease. In four patients suffering from mental retardation, the brain promoter region was also studied. To screen for point mutations, we applied molecular analysis by parallel denaturing gradient gel electrophoresis (DGGE). No sequence alterations were found in either the muscle or the brain promoters, suggesting that mutations in these regions do not represent a common mechanism of mutation in DMD/BMD.
Similar articles
-
Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients.Hum Mol Genet. 1993 Nov;2(11):1877-81. doi: 10.1093/hmg/2.11.1877. Hum Mol Genet. 1993. PMID: 8281150
-
DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients.Hum Mutat. 2004 Jan;23(1):57-66. doi: 10.1002/humu.10283. Hum Mutat. 2004. PMID: 14695533
-
Brain- and muscle-type promoters of the dystrophin gene are selected in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid [correction of lymphoplastoid] cells.J Neurol. 1993 Dec;241(2):81-6. doi: 10.1007/BF00869768. J Neurol. 1993. PMID: 8138829
-
Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosis.Clin Chem. 1989 Jul;35(7 Suppl):B21-4. Clin Chem. 1989. PMID: 2663232 Review.
-
Unraveling the mysteries of Duchenne and Becker muscular dystrophy.Mol Chem Neuropathol. 1989 Feb;10(1):15-20. doi: 10.1007/BF02969482. Mol Chem Neuropathol. 1989. PMID: 2660836 Review.
Cited by
-
The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.J Med Genet. 1997 Oct;34(10):805-12. doi: 10.1136/jmg.34.10.805. J Med Genet. 1997. PMID: 9350811 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical